TL;DR: Aetna, a CVS Health company, modified CPB 0549 governing distraction osteogenesis for craniofacial defects, effective November 27, 2025. Billing teams billing CPT 20692, 20693, 20694, 20696, and 20697 for Aetna members need to confirm the diagnosis maps to one of eight covered congenital indications—or expect a claim denial.
This Aetna distraction osteogenesis coverage policy update clarifies both what qualifies as medically necessary and what Aetna now explicitly calls experimental or cosmetic. The distinction matters enormously for craniofacial and oral-maxillofacial surgery practices. Get the wrong diagnosis on the prior authorization request and you're looking at a denial that's very hard to overturn. This post walks through every covered indication, every excluded one, and the billing guidelines your team needs before submitting claims under this updated policy.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Distraction Osteogenesis for Craniofacial Defects |
| Policy Code | CPB 0549 |
| Change Type | Modified |
| Effective Date | November 27, 2025 |
| Impact Level | High |
| Specialties Affected | Oral & Maxillofacial Surgery, Craniofacial Surgery, Pediatric Surgery, Plastic Surgery |
| Key Action | Audit all pending and future distraction osteogenesis prior authorization requests against the eight covered congenital indications before submitting claims |
Aetna Distraction Osteogenesis Coverage Criteria and Medical Necessity Requirements 2025
The Aetna distraction osteogenesis coverage policy under CPB 0549 draws a hard line: this procedure is medically necessary only for congenital craniofacial skeletal deformities accompanied by functional impairments. Cosmetic improvement alone doesn't qualify. That's not a subtle distinction—it's the difference between a paid claim and a flat denial.
Aetna defines eight specific congenital indications where distraction osteogenesis meets medical necessity. These cover CPT codes 20692, 20693, 20694, 20696, and 20697 for external fixation application, adjustment, revision, and removal.
Here are the eight covered indications, exactly as the policy defines them:
| # | Covered Indication |
|---|---|
| 1 | Cleft lip and palate |
| 2 | Hemifacial microsomia — in children with sufficient bone for a corticotomy and/or osteotomy and pin placement for external or internal distraction devices (Pruzansky Grade I and IIa mandibular deformity only) |
| 3 | Severe congenital mandibular deficiency — requiring mandible lengthening of more than 10 mm (orthognathic surgery handles smaller deformities under CPB 0095) |
| 4 | Severe micrognathia — such as Pierre Robin syndrome or Treacher Collins syndrome, in infants and children with airway obstruction |
| 5 | Short mandibular ramus lengthening — stretching of the pterygomasseteric sling |
| 6 | Non-syndromic craniosynostosis — bilateral or unilateral coronal, or sagittal |
| 7 | Syndromic craniosynostosis — Apert, Crouzon, and Pfeiffer syndromes |
| 8 | Widening of a narrow mandible or maxilla |
One additional pathway exists. Aetna's Oral and Maxillofacial Surgery Unit may approve distraction osteogenesis for other congenital craniofacial anomalies not on this list—but only when OMS review determines it can produce a degree of improvement unavailable through standard techniques. This is a narrow carve-out, not a general catch-all. Don't count on it without a thorough prior authorization submission with clinical documentation to match.
For reimbursement under this policy, the functional impairment must be documented clearly. Aesthetic concerns as a secondary benefit don't disqualify a claim—but they can't be the primary rationale. Your operative notes and prior auth documentation need to lead with function, not form.
Aetna Distraction Osteogenesis Exclusions and Non-Covered Indications
Aetna is explicit about what this policy does not cover. Three categories get the denial treatment: experimental indications, dental-related uses under excluding plans, and cosmetic procedures.
Experimental and investigational designations:
Aetna calls the following unproven, with insufficient clinical evidence to support coverage:
| # | Excluded Procedure |
|---|---|
| 1 | Acquired craniofacial defects — this includes reconstruction after tumor resection (e.g., osteosarcoma), ablative head and neck surgery, and obstructive sleep apnea. All three are explicitly excluded. |
| 2 | Bone formation enhancement at the osteotomy site — specifically, bone morphogenetic proteins and local injection of bone marrow aspirate and platelet gel during the distraction procedure. CPT codes 0232T (platelet-rich plasma injection) and 0481T (autologous white blood cell concentrate injection) fall into this not-covered bucket. |
The sleep apnea exclusion is worth flagging separately. Some craniofacial practices have explored distraction osteogenesis as an OSA intervention. Aetna's position is clear: not covered under this policy. See Aetna CPB 0004 (Obstructive Sleep Apnea in Adults) and CPB 0752 (Obstructive Sleep Apnea in Children) if that's a relevant question for your patient mix.
Dental implant and orthodontic exclusions:
If the patient's benefit plan excludes dental implants or orthodontic care, Aetna will not cover distraction osteogenesis when it's performed in preparation for those services. Check the benefit plan description before scheduling. This is a plan-level exclusion, not a clinical one—meaning it varies by employer group and individual plan. Your eligibility verification process needs to catch this before the procedure, not after.
Cosmetic:
Distraction osteogenesis performed solely to improve appearance or profile is cosmetic under this policy. No exceptions, no OMS review pathway. If the chart doesn't document a functional impairment, the claim won't survive review.
Coverage Indications at a Glance
| Indication | Status | Key CPT Codes | Notes |
|---|---|---|---|
| Cleft lip and palate | Covered | 20692, 20693, 20694, 20696, 20697 | Functional impairment must be documented |
| Hemifacial microsomia (Pruzansky Grade I and IIa) | Covered | 20692, 20693, 20694, 20696, 20697 | Must have sufficient bone for corticotomy/osteotomy; Grade IIb and III not listed |
| Severe congenital mandibular deficiency >10 mm | Covered | 20692, 20693, 20694, 20696, 20697 | Smaller deformities addressed under orthognathic surgery (CPB 0095) |
| Severe micrognathia with airway obstruction (Pierre Robin, Treacher Collins) | Covered | 20692, 20693, 20694, 20696, 20697 | Infants and children; airway obstruction must be documented |
| Short mandibular ramus lengthening | Covered | 20692, 20693, 20694, 20696, 20697 | Pterygomasseteric sling stretching |
| Non-syndromic craniosynostosis (coronal or sagittal) | Covered | 20692, 20693, 20694, 20696, 20697 | Bilateral or unilateral coronal; sagittal included |
| Syndromic craniosynostosis (Apert, Crouzon, Pfeiffer) | Covered | 20692, 20693, 20694, 20696, 20697 | Syndrome must be documented in diagnosis |
| Narrow mandible or maxilla widening | Covered | 20692, 20693, 20694, 20696, 20697 | Functional impairment required |
| Other congenital craniofacial anomalies not listed | Possible — OMS review required | 20692–20697 | Must show distraction produces improvement unavailable through standard techniques |
| Acquired craniofacial defects (post-tumor resection, head/neck surgery) | Not Covered — Experimental | — | Insufficient clinical evidence per Aetna |
| Obstructive sleep apnea | Not Covered — Experimental | — | See CPB 0004 and CPB 0752 |
| Bone formation enhancement (BMP, bone marrow aspirate, platelet gel) | Not Covered — Experimental | 0232T, 0481T | Insufficient peer-reviewed evidence |
| Preparation for dental implants or orthodontic care | Not Covered (plan-dependent) | — | Excluded under plans that exclude dental implants or orthodontic care |
| Cosmetic improvement only | Not Covered — Cosmetic | — | No functional impairment = cosmetic denial |
Aetna Distraction Osteogenesis Billing Guidelines and Action Items 2025
The effective date is November 27, 2025. If your practice bills distraction osteogenesis for Aetna members, these steps need to happen now.
| # | Action Item |
|---|---|
| 1 | Audit your prior authorization templates against all eight covered indications. Your PA requests need to map the patient's diagnosis to one of the eight listed congenital conditions. Vague language like "craniofacial deformity" will not be enough. Be specific: "Pruzansky Grade IIa hemifacial microsomia with documented functional impairment" is the kind of clinical specificity Aetna's OMS unit needs to approve. |
| 2 | Verify benefit plan dental exclusions before scheduling. For any case where distraction osteogenesis is part of a treatment plan that includes dental implants or orthodontics, check the patient's specific plan. Call the eligibility line or check the benefit summary. If the plan excludes dental or orthodontic care, document your review and discuss the coverage gap with the patient before the procedure. |
| 3 | Scrub claims that include CPT 0232T or 0481T alongside distraction osteogenesis. Aetna considers platelet-rich plasma (0232T) and autologous white blood cell concentrate (0481T) experimental for this indication. Billing them together with 20692–20697 will generate a denial for those add-on codes. If your surgeons use these adjuncts, make sure patients understand there's no Aetna reimbursement for those components. |
| 4 | Flag any acquired defect or OSA cases before they get prior authorization submissions. Distraction osteogenesis billing for post-tumor reconstruction or sleep apnea treatment is experimental under CPB 0549. A prior authorization request for these indications will be denied. Redirect those cases to the appropriate policy (CPB 0004 or CPB 0752 for OSA) or prepare for patient financial responsibility conversations. |
| 5 | Document functional impairment explicitly in operative notes and supporting records. This policy requires functional impairment as the basis for medical necessity. For airway obstruction cases (Pierre Robin, Treacher Collins), document the obstruction severity. For mandibular deficiency cases, document the functional deficit and the measurement—particularly the greater-than-10-mm threshold that separates distraction osteogenesis from orthognathic surgery eligibility. |
| 6 | If your patient mix includes atypical congenital anomalies not on the eight-indication list, loop in your billing consultant or compliance officer before submitting. The OMS review pathway exists, but it's discretionary. Without a clear clinical argument that distraction osteogenesis uniquely produces improvement over standard techniques, that request is likely to be denied. Build that argument before submission, not after. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Distraction Osteogenesis Under CPB 0549
Covered CPT Codes (When Selection Criteria Are Met)
These five codes are the core of distraction osteogenesis billing under this policy. Coverage requires the diagnosis to map to one of the eight approved congenital indications.
| Code | Type | Description |
|---|---|---|
| 20692 | CPT | Application of multiplane (pins or wires in more than one plane), unilateral, external fixation system |
| 20693 | CPT | Adjustment or revision of external fixation system requiring anesthesia (e.g., new pin(s) or wire(s)) |
| 20694 | CPT | Removal, under anesthesia, of external fixation system |
| 20696 | CPT | Application of multiplane (pins or wires in more than one plane), unilateral, external fixation with stereotactic computer-assisted adjustment |
| 20697 | CPT | Exchange (i.e., removal and replacement) of strut, each |
Not Covered / Experimental Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 0232T | CPT | Injection(s), platelet-rich plasma, any site, including image guidance, harvesting and preparation when performed | Experimental — insufficient peer-reviewed evidence for this indication |
| 0481T | CPT | Injection(s), autologous white blood cell concentrate (autologous protein solution), any site | Experimental — insufficient peer-reviewed evidence for this indication |
Get the Full Picture for CPT 20692
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.